| 國立成功大學 |
2023 |
Long-term use and risk of major adverse cardiac events: Comparing enzalutamide and abiraterone in chemotherapy-na�ve patients with metastatic castration-resistant prostate cancer
|
Chen, H.-K.;Su, P.-J.;Wang, Y.-L.;Chang, K.-C.;Su, Y.-L.;Chang, P.-H.;Kuan, F.-C.;Hsieh, C.-H.;Kuo, Y.-C.;Sheng, T.-W.;Chang, Chang C.-F.;Yu, S.-M.;Huang, W.-K.;Lin, Y.-C.;Tsan, D.-L.;Yu, K.-J.;Lin, P.-H.;Chen, H.-Y.;Chang, Y.-H.;Pang, S.-T.;Chuang, Chuang C.-K.;Lai, E.C.-C. |
| 臺大學術典藏 |
2022-09-15T09:48:03Z |
Identifying Epstein?�Barr virus peptide sequences associated with differential IgG antibody response
|
Coghill A.E.; Fang J.; Liu Z.; Chen C.-J.; Jarrett R.F.; Hjalgrim H.; Proietti C.; Yu K.J.; Hsu W.-L.; PEI-JEN LOU; Wang C.-P.; Zhao Y.; Doolan D.L.; Hildesheim A. |
| 臺大學術典藏 |
2022-04-20T08:12:04Z |
Cancer patterns in nasopharyngeal carcinoma multiplex families over 15 years
|
Yu K.J.; Hsu W.-L.; CHUN-JU CHIANG; Chen T.-C.; Liu Z.; Lou P.-J.; Diehl S.; Goldstein A.M.; Chen C.-J.; Wang C.-P.; Hildesheim A. |
| 臺大學術典藏 |
2022-04-20T07:19:09Z |
Evaluation of rare and common variants from suspected familial or sporadic nasopharyngeal carcinoma (NPC) susceptibility genes in sporadic NPC
|
Liu Z.; Goldstein A.M.; Hsu W.-L.; Yu K.J.; Chien Y.-C.; Ko J.-Y.; Jian J.J.-M.; Tsou Y.-A.; Leu Y.-S.; Liao L.-J.; Chang Y.-L.; Wang C.-P.; Wu J.-S.; Hua C.-H.; Lee J.-C.; Yang T.-L.; CHUHSING KATE HSIAO; Wu M.-S.; Tsai M.-H.; Huang K.-K.; Yu K.; Jones K.; Zhu B.; Yeager M.; Yu G.; Lou P.-J.; Chen C.-J.; Hildesheim A.; for the GEV-NPC group |
| 臺大學術典藏 |
2021-11-18T04:57:50Z |
Evaluation of rare and common variants from suspected familial or sporadic nasopharyngeal carcinoma (NPC) susceptibility genes in sporadic NPC
|
Liu Z; Goldstein A.M; Hsu W.-L; Yu K.J; Chien Y.-C; JENG-YUH KO; Jian J.J.-M; Tsou Y.-A; Leu Y.-S; Liao L.-J; Chang Y.-L; Wang C.-P; Wu J.-S; Hua C.-H; Lee J.-C; Yang T.-L; Hsiao C.K; Wu M.-S; Tsai M.-H; Huang K.-K; Yu K; Jones K; Zhu B; Yeager M; Yu G; Lou P.-J; Chen C.-J; Hildesheim A; for the GEV-NPC group |
| 臺大學術典藏 |
2021-11-18T04:57:47Z |
Cigarette smoking increases the risk of nasopharyngeal carcinoma through the elevated level of IgA antibody against Epstein-Barr virus capsid antigen: A mediation analysis
|
Hsu W.-L; Chien Y.-C; Huang Y.-T; Yu K.J; JENG-YUH KO; Lin C.-Y; Tsou Y.-A; Leu Y.-S; Liao L.-J; Chang Y.-L; Su J.-Y; Liu Z; Wang C.-P; Terng S.-D; Hua C.-H; Lee J.-C; Yang T.-L; Kate Hsiao C.-H; Wu M.-S; Tsai M.-H; Liu M.-J; Lou P.-J; Hildesheim A; Chen C.-J; the GEV-NPC Study Group |
| 臺大學術典藏 |
2021-11-15T07:48:11Z |
Evaluation of rare and common variants from suspected familial or sporadic nasopharyngeal carcinoma (NPC) susceptibility genes in sporadic NPC
|
Liu Z; Goldstein A.M; Hsu W.-L; Yu K.J; Chien Y.-C; JENG-YUH KO; Jian J.J.-M; Tsou Y.-A; Leu Y.-S; Liao L.-J; Chang Y.-L; Wang C.-P; Wu J.-S; Hua C.-H; Lee J.-C; Yang T.-L; Hsiao C.K; Wu M.-S; Tsai M.-H; Huang K.-K; Yu K; Jones K; Zhu B; Yeager M; Yu G; Lou P.-J; Chen C.-J; Hildesheim A; for the GEV-NPC group |
| 臺大學術典藏 |
2021-11-15T07:48:08Z |
Cigarette smoking increases the risk of nasopharyngeal carcinoma through the elevated level of IgA antibody against Epstein-Barr virus capsid antigen: A mediation analysis
|
Hsu W.-L; Chien Y.-C; Huang Y.-T; Yu K.J; JENG-YUH KO; Lin C.-Y; Tsou Y.-A; Leu Y.-S; Liao L.-J; Chang Y.-L; Su J.-Y; Liu Z; Wang C.-P; Terng S.-D; Hua C.-H; Lee J.-C; Yang T.-L; Kate Hsiao C.-H; Wu M.-S; Tsai M.-H; Liu M.-J; Lou P.-J; Hildesheim A; Chen C.-J; the GEV-NPC Study Group |
| 臺大學術典藏 |
2021-10-14T02:45:20Z |
Genomic characterization of clear cell renal cell carcinoma using targeted gene sequencing
|
LIN P.-H.; CHAO-YUAN HUANG; YU K.-J.; KAN H.-C.; LIU C.-Y.; CHUANG C.-K.; LU Y.-C.; CHANG Y.-H.; SHAO I.H.; PANG S.-T. |
| 臺大學術典藏 |
2021-05-07T06:02:40Z |
Cancer patterns in nasopharyngeal carcinoma multiplex families in Taiwan
|
Yu K.J.; Hsu W.-L.; CHUN-JU CHIANG; Cheng Y.-J.; Pfeiffer R.M.; Diehl S.R.; Goldstein A.M.; Gravitt P.E.; Chen C.-J.; Hildesheim A. |
| 臺大學術典藏 |
2021-05-07T06:02:39Z |
Prognostic utility of anti-EBV antibody testing for defining NPC risk among individuals from high-risk NPC families
|
Yu K.J.;Hsu W.-L.;Pfeiffer R.M.;Chun-Ju Chiang ;Wang C.-P.;Lou P.-J.;Cheng Y.-J.;Gravitt P.;Diehl S.R.;Goldstein A.M.;Chen C.-J.;Hildesheim A.; Yu K.J.; Hsu W.-L.; Pfeiffer R.M.; CHUN-JU CHIANG; Wang C.-P.; Lou P.-J.; Cheng Y.-J.; Gravitt P.; Diehl S.R.; Goldstein A.M.; Chen C.-J.; Hildesheim A. |
| 臺大學術典藏 |
2021-05-07T06:02:39Z |
Familial tendency and risk of nasopharyngeal carcinoma in Taiwan: Effects of covariates on risk
|
Hsu W.-L.;Yu K.J.;Chien Y.-C.;Chun-Ju Chiang ;Cheng Y.-J.;Chen J.-Y.;Liu M.-Y.;Chou S.-P.;You S.-L.;Hsu M.-M.;Lou P.-J.;Wang C.-P.;Hong J.-H.;Leu Y.-S.;Tsai M.-H.;Su M.-C.;Tsai S.-T.;Chao W.-Y.;Ger L.-P.;Chen P.-R.;Yang C.-S.;Hildesheim A.;Diehl S.R.;Chen C.-J.; Hsu W.-L.; Yu K.J.; Chien Y.-C.; CHUN-JU CHIANG; Cheng Y.-J.; Chen J.-Y.; Liu M.-Y.; Chou S.-P.; You S.-L.; Hsu M.-M.; Lou P.-J.; Wang C.-P.; Hong J.-H.; Leu Y.-S.; Tsai M.-H.; Su M.-C.; Tsai S.-T.; Chao W.-Y.; Ger L.-P.; Chen P.-R.; Yang C.-S.; Hildesheim A.; Diehl S.R.; Chen C.-J. |
| 臺大學術典藏 |
2021-05-07T06:02:34Z |
Lifetime risk of distinct upper aerodigestive tract cancers and consumption of alcohol, betel and cigarette
|
Hsu W.-L.;Chien Y.-C.;Chun-Ju Chiang;Yang H.-I.;Lou P.-J.;Wang C.-P.;Yu K.J.;You S.-L.;Wang L.-Y.;Chen S.-Y.;Yang C.-S.;Chen C.-J.; Hsu W.-L.; Chien Y.-C.; CHUN-JU CHIANG; Yang H.-I.; Lou P.-J.; Wang C.-P.; Yu K.J.; You S.-L.; Wang L.-Y.; Chen S.-Y.; Yang C.-S.; Chen C.-J. |
| 臺大學術典藏 |
2021-03-03T03:00:57Z |
Corrigendum to "Results of a randomized, double-blind, placebo-controlled study of mirabegron in a Taiwanese population with overactive bladder and comparison with other clinical trials", [Urol Sci, (2015), 41-48], doi:10.1016/j.urols.2014.12.010
|
Kuo H.-C.; HO-HSIUNG LIN; Yu H.-J.; Cheng C.-L.; Hung M.-J.; Lin A.T.L.; Chang C.-H.; Chuang Y.-C.; Cha T.-L.; Chen G.-D.; Chen C.-S.; Wu M.-P.; Wu T.-L.; Yu K.-J.; Huang S.-T.; The Taiwan Mirabegron Study Team |
| 臺大學術典藏 |
2021-02-02T02:20:50Z |
Evaluation of rare and common variants from suspected familial or sporadic nasopharyngeal carcinoma (NPC) susceptibility genes in sporadic NPC
|
Liu Z.; Goldstein A.M.; Hsu W.-L.; Yu K.J.; Chien Y.-C.; Ko J.-Y.; Jian J.J.-M.; Tsou Y.-A.; Leu Y.-S.; Liao L.-J.; Chang Y.-L.; Wang C.-P.; Wu J.-S.; Hua C.-H.; Lee J.-C.; Yang T.-L.; Hsiao C.K.; MING-SHIANG WU; Tsai M.-H.; Huang K.-K.; Yu K.; Jones K.; Zhu B.; Yeager M.; Yu G.; Lou P.-J.; Chen C.-J.; Hildesheim A.; for the GEV-NPC group |
| 臺大學術典藏 |
2021-02-02T02:20:41Z |
Cigarette smoking increases the risk of nasopharyngeal carcinoma through the elevated level of IgA antibody against Epstein-Barr virus capsid antigen: A mediation analysis
|
Hsu W.-L.; Chien Y.-C.; Huang Y.-T.; Yu K.J.; Ko J.-Y.; Lin C.-Y.; Tsou Y.-A.; Leu Y.-S.; Liao L.-J.; Chang Y.-L.; Su J.-Y.; Liu Z.; Wang C.-P.; Terng S.-D.; Hua C.-H.; Lee J.-C.; Yang T.-L.; Kate Hsiao C.-H.; MING-SHIANG WU; Tsai M.-H.; Liu M.-J.; Lou P.-J.; Hildesheim A.; Chen C.-J.; the GEV-NPC Study Group |
| 臺大學術典藏 |
2021-02-02T00:43:02Z |
Corrigendum to "Results of a randomized, double-blind, placebo-controlled study of mirabegron in a Taiwanese population with overactive bladder and comparison with other clinical trials", [Urol Sci, (2015), 41-48], doi:10.1016/j.urols.2014.12.010
|
Kuo H.-C.; Lin H.-H.; HONG-JENG YU; Cheng C.-L.; Hung M.-J.; Lin A.T.L.; Chang C.-H.; Chuang Y.-C.; Cha T.-L.; Chen G.-D.; Chen C.-S.; Wu M.-P.; Wu T.-L.; Yu K.-J.; Huang S.-T.; The Taiwan Mirabegron Study Team |
| 臺大學術典藏 |
2021-01-28T08:27:29Z |
Genomic characterization of clear cell renal cell carcinoma using targeted gene sequencing
|
LIN P.-H.; HUANG C.-Y.; YU K.-J.; KAN H.-C.; LIU C.-Y.; CHUANG C.-K.; YU-CHUAN LU; CHANG Y.-H.; SHAO I.H.; PANG S.-T. |
| 臺大學術典藏 |
2020-11-03T15:39:36Z |
Familial tendency and risk of nasopharyngeal carcinoma in Taiwan: Effects of covariates on risk
|
Chen P.-R; Yang C.-S; Hildesheim A; Diehl S.R; Chen C.-J.; Hsu M.-M; Lou P.-J; CHENG-PING WANG; Hong J.-H; Leu Y.-S; Tsai M.-H; Su M.-C; Tsai S.-T; Chao W.-Y; Ger L.-P; Chou S.-P; You S.-L; Chen J.-Y; Liu M.-Y; Cheng Y.-J; Chiang C.-J; Chien Y.-C; Yu K.J; Hsu W.-L |
| 臺大學術典藏 |
2020-11-03T15:39:35Z |
Prognostic utility of anti-EBV antibody testing for defining NPC risk among individuals from high-risk NPC families
|
Yu K.J; Hsu W.-L; Pfeiffer R.M; Chiang C.-J; CHENG-PING WANG; Lou P.-J; Cheng Y.-J; Gravitt P; Diehl S.R; Goldstein A.M; Chen C.-J; Hildesheim A. |
| 臺大學術典藏 |
2020-11-03T15:39:32Z |
Characterization of ELISA detection of broad-spectrum anti-Epstein-Barr virus antibodies associated with nasopharyngeal carcinoma
|
Chang C; Middeldorp J; Yu K.J; Juwana H; Hsu W.-L; Lou P.-J; CHENG-PING WANG; Chen J.-Y; Liu M.-Y; Pfeiffer R.M; Chen C.-J; Hildesheim A. |
| 臺大學術典藏 |
2020-11-03T15:39:30Z |
Epstein-barr virus serology as a potential screening marker for nasopharyngeal carcinoma among high-risk individuals from multiplex families in Taiwan
|
Yu K.J; Lou P.-J; CHENG-PING WANG; Chen J.-Y; Chen C.-J; Middeldorp J.M; Hildesheim A.; Coghill A.E; Hsu W.-L; Pfeiffer R.M; Juwana H |
| 臺大學術典藏 |
2020-11-03T15:39:27Z |
Lifetime risk of distinct upper aerodigestive tract cancers and consumption of alcohol, betel and cigarette
|
Chien Y.-C; Chiang C.-J; Yang H.-I; Lou P.-J; CHENG-PING WANG; Yu K.J; You S.-L; Wang L.-Y; Chen S.-Y; Yang C.-S; Chen C.-J.; Hsu W.-L |
| 臺大學術典藏 |
2020-11-03T15:39:25Z |
High levels of antibody that neutralize b-cell infection of Epstein-barr virus and that bind ebv gp350 are associated with a lower risk of nasopharyngeal carcinoma
|
Coghill A.E; Bu W; Nguyen H; Hsu W.-L; Yu K.J; Lou P.-J; CHENG-PING WANG; Chen C.-J; Hildesheim A; Cohen J.I. |
| 臺大學術典藏 |
2020-11-03T15:39:22Z |
Patterns of Interindividual Variability in the Antibody Repertoire Targeting Proteins Across the Epstein-Barr Virus Proteome
|
Liu Z; Coghill A.E; Pfeiffer R.M; Proietti C; Hsu W.-L; Chien Y.-C; Lekieffre L; Krause L; Yu K.J; Lou P.-J; CHENG-PING WANG; Mulvenna J; Middeldorp J.M; Bethony J; Chen C.-J; Doolan D.L; Hildesheim A. |
